Literature DB >> 26514576

Serial imaging and outcome prediction.

Ami E Iskandrian1, Christopher P Roth2, Fadi G Hage2,3.   

Abstract

Mesh：

Year:  2015        PMID： 26514576     DOI： 10.1007/s12350-015-0312-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

1.  Detection of serial changes in absolute myocardial perfusion with 82Rb PET.

Authors:  R A deKemp; T D Ruddy; T Hewitt; M M Dalipaj; R S Beanlands
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

Review 2.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

3.  Detecting changes in serial myocardial perfusion SPECT: a simulation study.

Authors:  Tracy L Faber; Jan Modersitzki; Russell D Folks; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

4.  Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.

Authors:  Stephanie El-Hajj; Wael A AlJaroudi; Ayman Farag; Steven Bleich; Padma Manaoragada; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-05-28       Impact factor: 5.952

Review 5.  Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging.

Authors:  Leslee J Shaw; Daniel S Berman; Michael H Picard; Matthias G Friedrich; Raymond Y Kwong; Gregg W Stone; Roxy Senior; James K Min; Rory Hachamovitch; Marielle Scherrer-Crosbie; Jennifer H Mieres; Thomas H Marwick; Lawrence M Phillips; Farooq A Chaudhry; Patricia A Pellikka; Piotr Slomka; Andrew E Arai; Ami E Iskandrian; Timothy M Bateman; Gary V Heller; Todd D Miller; Eike Nagel; Abhinav Goyal; Salvador Borges-Neto; William E Boden; Harmony R Reynolds; Judith S Hochman; David J Maron; Pamela S Douglas
Journal:  JACC Cardiovasc Imaging       Date:  2014-06

Review 6.  Tracking a therapeutic response: how reliable are serial measurements of LV perfusion and function?

Authors:  Guido Germano; Paul B Kavanagh; Piotr J Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

7.  Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.

Authors:  Leslee J Shaw; Robert Hendel; Salvador Borges-Neto; Michael S Lauer; Naomi Alazraki; Joy Burnette; Elizabeth Krawczynska; Manuel Cerqueira; Jamshid Maddahi
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

8.  Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

Authors:  Michael J Zellweger; Michael Maraun; Hans H Osterhues; Ulrich Keller; Jan Müller-Brand; Raban Jeger; Otmar Pfister; Thilo Burkard; Friedrich Eckstein; Stefanie von Felten; Stefan Osswald; Matthias Pfisterer
Journal:  JACC Cardiovasc Imaging       Date:  2014-09-17

9.  Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.

Authors:  John J Mahmarian; Leif E Peterson; Jiaqiong Xu; Manuel D Cerqueira; Ami E Iskandrian; Timothy M Bateman; Gregory S Thomas; Faisal Nabi
Journal:  J Nucl Cardiol       Date:  2014-10-07       Impact factor: 5.952

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
View more
  5 in total

1.  Caffeine does not significantly reduce the sensitivity of vasodilator stress myocardial perfusion imaging.

Authors:  Rayan Saab; Navkaranbir S Bajaj; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-12-14       Impact factor: 5.952

2.  Serial cardiac SPECT studies: Technical issues and clinical implications.

Authors:  Alberto Cuocolo; Raymond Taillefer
Journal:  J Nucl Cardiol       Date:  2016-10-27       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2017-04-06       Impact factor: 5.952

4.  Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015-Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2016-02-18       Impact factor: 5.952

Review 5.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.